One of the serotonin uptake inhibitors formerly used for depression but was withdrawn worldwide in September 1983 because of the risk of guillain-barre syndrome associated with its use. (From Martindale, The Extra Pharmacopoeia, 29th ed, p385)

Symptoms and diagnosis



We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.